Labcorp Holdings, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5049221055
USD
263.80
0.89 (0.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

471.2 k

Shareholding (Dec 2025)

FII

18.16%

Held by 350 FIIs

DII

37.68%

Held by 55 DIIs

Promoter

0.00%

Is Labcorp Holdings, Inc. technically bullish or bearish?

20-Sep-2025

As of October 1, 2023, Labcorp Holdings, Inc. shows a bullish overall technical stance with strong MACD signals and positive performance, despite some caution from Dow Theory on the monthly timeframe.

As of 1 October 2023, the technical stance for Labcorp Holdings, Inc. is bullish overall, with a strong bullish signal from the MACD on both weekly and monthly time frames. The daily moving averages also indicate bullish momentum. Additionally, the Bollinger Bands and OBV show mildly bullish trends on both weekly and monthly periods. However, Dow Theory suggests a mildly bearish stance on the monthly timeframe, indicating some caution. <BR><BR>In terms of performance, Labcorp has outperformed the S&P 500 year-to-date with a return of 20.86% compared to the S&P 500's 12.22%, and over the past year, it has also outperformed with a return of 21.97% versus 17.14%. Overall, the bullish indicators suggest a positive outlook despite some mixed signals in the longer-term trends.

View full answer

Is Labcorp Holdings, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Labcorp Holdings, Inc. is fairly valued with a P/E ratio of 28.86 and has outperformed the S&P 500 with a year-to-date return of 24.69% and a one-year return of 32.91%.

As of 17 October 2025, the valuation grade for Labcorp Holdings, Inc. has moved from expensive to fair. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 28.86, an EV to EBITDA of 14.80, and a PEG ratio of 0.0. In comparison, peers in the Pharmaceuticals & Biotechnology industry exhibit varying valuations, with notable competitors having different P/E ratios that reflect their market positions.<BR><BR>In terms of performance, Labcorp has demonstrated strong returns, with a year-to-date return of 24.69% compared to the S&P 500's 13.30%, and a one-year return of 32.91% versus the S&P 500's 14.08%. This performance indicates that while Labcorp is fairly valued, it has outperformed the broader market over multiple periods, reinforcing its competitive position within the industry.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Positive results in Jun 25

  • OPERATING CASH FLOW(Y) Highest at USD 1,693.6 MM
  • NET SALES(Q) Highest at USD 3,527.3 MM
  • INTEREST COVERAGE RATIO(Q) Highest at 996.32
2

With ROE of 0.00%, it has a valuation with a 0.00 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 23,433 Million (Mid Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.61

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

2.72

Revenue and Profits:
Net Sales:
3,516 Million
(Quarterly Results - Dec 2025)
Net Profit:
165 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.14%
0%
-0.14%
6 Months
-5.09%
0%
-5.09%
1 Year
11.95%
0%
11.95%
2 Years
22.27%
0%
22.27%
3 Years
20.32%
0%
20.32%
4 Years
15.66%
0%
15.66%
5 Years
28.64%
0%
28.64%

Labcorp Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-0.04%
EBIT Growth (5y)
-12.50%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
27.53%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
2.85
EV to EBIT
23.74
EV to EBITDA
15.39
EV to Capital Employed
2.16
EV to Sales
2.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.08%
ROE (Latest)
9.42%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 138 Schemes (43.85%)

Foreign Institutions

Held by 350 Foreign Institutions (18.16%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -1.34% vs 1.03% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -36.94% vs 9.74% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,515.80",
          "val2": "3,563.50",
          "chgp": "-1.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "555.00",
          "val2": "574.20",
          "chgp": "-3.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "55.00",
          "val2": "56.00",
          "chgp": "-1.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-114.40",
          "val2": "-6.60",
          "chgp": "-1,633.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "164.90",
          "val2": "261.50",
          "chgp": "-36.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "108.70%",
          "val2": "113.10%",
          "chgp": "-0.44%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.25% vs 6.97% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 17.48% vs 96.40% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13,951.70",
          "val2": "13,008.90",
          "chgp": "7.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,477.30",
          "val2": "2,037.90",
          "chgp": "21.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "224.10",
          "val2": "208.30",
          "chgp": "7.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-142.60",
          "val2": "-51.30",
          "chgp": "-177.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "877.70",
          "val2": "747.10",
          "chgp": "17.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "108.70%",
          "val2": "87.50%",
          "chgp": "2.12%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
3,515.80
3,563.50
-1.34%
Operating Profit (PBDIT) excl Other Income
555.00
574.20
-3.34%
Interest
55.00
56.00
-1.79%
Exceptional Items
-114.40
-6.60
-1,633.33%
Consolidate Net Profit
164.90
261.50
-36.94%
Operating Profit Margin (Excl OI)
108.70%
113.10%
-0.44%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -1.34% vs 1.03% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -36.94% vs 9.74% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
13,951.70
13,008.90
7.25%
Operating Profit (PBDIT) excl Other Income
2,477.30
2,037.90
21.56%
Interest
224.10
208.30
7.59%
Exceptional Items
-142.60
-51.30
-177.97%
Consolidate Net Profit
877.70
747.10
17.48%
Operating Profit Margin (Excl OI)
108.70%
87.50%
2.12%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 7.25% vs 6.97% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 17.48% vs 96.40% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details